Topical sustainable ophthalmic nanoparticle drug delivery systems for improving the treatment of cataract / Ruddy Moneer Abdalrahman ; Supervised Alya Abalateef Badawy , Magdy Ibrahim Mohammed , Rawia Mohamed Khalil
Material type:
- صياغات عينية موضعية نانومترية ممتدة المفعول لتحسين علاج إعتام عدسة العين [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.08.08.Ph.D.2021.Ru.T (Browse shelf(Opens below)) | Not for loan | 01010110084981000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.08.08.Ph.D.2021.Ru.T (Browse shelf(Opens below)) | 84981.CD | Not for loan | 01020110084981000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | ||
Cai01.08.08.Ph.D.2021.Ra.P A pharmaceutical study on a drug in topical delivery systems / | Cai01.08.08.Ph.D.2021.Ra.P A pharmaceutical study on a drug in topical delivery systems / | Cai01.08.08.Ph.D.2021.Ru.T Topical sustainable ophthalmic nanoparticle drug delivery systems for improving the treatment of cataract / | Cai01.08.08.Ph.D.2021.Ru.T Topical sustainable ophthalmic nanoparticle drug delivery systems for improving the treatment of cataract / | Cai01.08.08.Ph.D.2021.Sa.I Improvement availability of drug for certain eye delivery systems / | Cai01.08.08.Ph.D.2021.Sa.I Improvement availability of drug for certain eye delivery systems / | Cai01.08.08.Ph.D.2021.Sh.D Different nanovesicular carriers for enhanced topical delivery for a certain drug model / |
Thesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics
Cataract is an opacification of all or specific regions of the lens that results in obstruction of light and gradual loss of vision. It continues to be the leading cause of blindness worldwide, accounting for over 50% of the world{u2019}s blind population.The underlying causes of cataract are quite diverse with the majority of cataracts acquired after middle age. Congenital or juvenile cataracts, considered as early onset cataracts, are less common but nonetheless have significant visual consequences.L-Carnosine (b-alanyl-L-histidine) is generally found in milli-Mole (mM) concentrations in several mammalian tissues, potentially exhibiting different metabolic activities. The previously published data suggest that L-carnosine has excellent potential to act as a natural antioxidant with hydroxyl radical, singlet oxygen scavenging and lipid peroxidase activities. A striking effect of L-carnosine is its demonstrated ability to prevent, or partially reverse, lens cataract. The N-acetyl derivative of carnosine (NAC) of carnosine exists in the cardiac and skeletal mammalian muscles and the total concentration of these imidazoles may lie within the measured range of L-carnosine in skeletal muscle.The advantage of NAC to act as an in vivo universal antioxidant with physiological and therapeutic relevance deals with its ability to give efficient protection against oxidative stress in the lipid phase of biological membranes and in aqueous environment due to turnover into L-carnosine. Due to its relative hydrophobicity compared with L-carnosine, NAC might penetrate through the cornea gradually, thus maintaining longer the active therapeutic concentration of L-carnosine in aqueous humor of the treated eye
Issued also as CD
There are no comments on this title.